A European Union that ensures patient access and sustainability

Related Posts

• New report reveals need for pricing and reimbursement and… 1 March 2021
• European Parliament report calls for increased use of… 24 November 2021 Open
• European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
• OECD and EUIPO publish study on counterfeit medicinal… 23 March 2020 Today the OECD and the European Union Intellectual Property Office…